Leonardo Biosystems said this week that it has received the second half of a $2.5 million grant from the Texas Emerging Technology Fund to help develop its multi-stage drug-delivery technology.
The first half of the grant was received in April 2010.
The program will recruit women with technology-development or business experience and provide them with entrepreneurial training and support over the course of a year, and will cull available technologies from universities throughout Texas under a grant from the Texas Emerging Technology Fund.
Former Introgen Therapeutics CEO David Nance founded the non-profit to promote tech commercialization and economic development by linking in-state academic researchers, angel and VC investors, entrepreneurs, and incubators.
Gaithersburg West Master Plan, Ben Franklin Technology Partners, University of Houston Institute of Biomedical Research, Connecticut Economic Development Consolidations, South San Francisco Life Sciences Career Fair, New York City Biotechnology Tax Credit